Document is current
Any future updates will be listed below
-
Authors
Aksnes, Mari http://orcid.org/0000-0002-7595-527X
Edwin, Trine H.
Saltvedt, Ingvild
Eldholm, Rannveig S.
Chaudhry, Farrukh A.
Halaas, Nathalie B.
Myrstad, Marius
Watne, Leiv O.
Knapskog, Anne-Brita
-
Funding
Funding for this research was provided by:
Olav Thon Stiftelsen
Nasjonalforeningen for Folkehelsen (25633)
Helse Sør-Øst RHF
Bærum Hospital Vestre Viken Trust
University of Oslo
- License Information
-
More Information
Article History
Received: 19 September 2022
Accepted: 21 April 2023
First Online: 23 May 2023
Declarations
:
: All patients and controls gave their informed written consent for participation in line with the Declaration of Helsinki. This study was approved by the Norwegian Regional Committees for Medical and Health Research Ethics (REC South East, 2017/371 and 2011/2052) and the Data Protector Officer at Oslo University Hospital.
: Not applicable.
: ABK and THE have been investigators on the clinical trial Roche BN29553; ABK, THE and IS have worked on the Boehringer-Ingelheim clinical trial 1346.0023; and ABK has worked on the Novo Nordisk drug trial NN6535-4730. The remaining authors declare no competing interests.
